Stuart A. Aaronson, M.D., Aron Professor and Founding Chair, Emeritus, Oncological Sciences, Icahn School of Medicine at Mount Sinai
Yasmina Abdiche, Ph.D., Research Fellow, Rinat-Pfizer
Gregory P. Adams, Ph.D., Co-Leader, Developmental Therapeutics Program, Fox Chase Cancer Center
Nabil M. Ahmed, M.D., MPH, Assistant Professor, Pediatrics Center for Cell and Gene Therapy, Baylor College of Medicine
Woo Suk Ahn, Ph.D., Research Associate, Bioinformatics and Metabolic Engineering, Massachusetts Institute of Technology (MIT)
Jeff Allen, Ph.D., Director, Analytical Biochemistry & Protein Purification, Pfenex Inc.
Luis Álvarez-Vallina, M.D., Ph.D., Molecular Immunology Unit, Hospital Universitario Puerta de Hierro
Lakshmi Amaravadi, Ph.D., Senior Director, Translational Medicine, Biogen Idec, Inc.
Christian Antoni, M.D., Ph.D., Vice President, Senior Global Program Head, Integrated Hospital Care Franchise, Novartis Pharmaceuticals Corporation
Tudor Arvinte, Ph.D., Professor, Department of Biopharmaceutics, University of Geneva; CEO, Therapeomic Inc.
Claire Ashman, BSc (Hons), Senior Scientific Investigator, Biopharm Innovation and R&D, GlaxoSmithKline Medicines Research Centre
René Assenberg, Ph.D., Research Investigator, Novartis Pharma AG
Michael B. Atkins, M.D., Deputy Director, Georgetown-Lombardi Comprehensive Cancer Center; Professor, Oncology and Medicine, Georgetown University Medical Center
William Bachovchin, Ph.D., Professor, Developmental, Molecular & Chemical Biology, Sackler School of Graduate and Biomedical Sciences, Tufts University
Yun Bai, Ph.D., Associate Director, Process Development, Ambrx, Inc.
Sathy Balu-Iyer, Ph.D., Associate Professor, Pharmaceutical Sciences, SUNY-University at Buffalo
Neil Bander, M.D., Professor, Weill Cornell Medical College
Maria Barbosa, Ph.D., CA Consultants; former Senior Principal Scientist, Bioanalytical Sciences, Bristol-Myers Squibb
Robin Barbour, Head, Antibody Generation, Research, Prothena Biosciences
Rachel Behan Wollacott, Ph.D., R&D Scientist II, MassBiologics
Bryan Berger, Ph.D., Head, Berger Lab; Assistant Professor, Chemical Engineering, Lehigh University
Alison Betts, Modeling and Simulation Leader, Associate Research Fellow, Translational Research Group, Pharmacokinetics, Dynamics & Metabolism, Pfizer Global R&D
Mary Birchler, Investigator, Clinical Immunology, GlaxoSmithKline, Inc.
Stanislas Blein, Ph.D., Deputy Director, Antibody Engineering, Biologics Research, Glenmark Pharmaceuticals S.A.
Piotr Bobrowicz, Ph.D., Director, Open Innovation, Adimab, LLC
Christophe Bonny, Ph.D., CSO, Bicycle Therapeutics, Ltd.
Ezio Bonvini, M.D., Senior Vice President, Research, MacroGenics, Inc.
Ellen Border, D.Phil., Senior Scientist, Protein Engineering, Adaptimmune Ltd.
Adrian Bot, M.D., Ph.D., Vice President, Translational Medicine, Kite Pharma, Inc.
Anne Bousseau, Head, Early Development Projects Oncology, Sanofi-Aventis
James Brady, Ph.D., MBA, Director, Technical Applications, MaxCyte
Daniel G. Bracewell, Ph.D., Reader, Biochemical Engineering, University College London
Malcolm Brenner, M.D., Ph.D., Professor, Departments of Pediatrics and Medicine; Stem Cells and Regenerative Medicine (STaR) Center; Program in Translational Biology & Molecular Medicine; Director, Center for Cell and Gene Therapy, Baylor College of Medicine
Joanna E. Brewer, Ph.D., Group Leader, Cellular Biology, Adaptimmune Ltd.
Ulrich Brinkmann, Ph.D., Scientific Director, Pharma Research and Early Development, Roche
Flavia Brunstein, M.D., Ph.D., Safety Science Leader, Early Development, Genentech
Peter Bruenker, Ph.D., Large Molecule Research, Pharma Research and Early Development (pRED), Roche Glycart AG
Stuart Bussell, Ph.D., Senior Director, Fermentation/Upstream Development, Sutro Biopharma
Scott Camberg, MS, Principal Scientist, Process Development, Amgen
Irwin Chaiken Ph.D., Professor, Biochemistry and Molecular Biology Drexel University College of Medicine
Yong S. Chang, Ph.D., Vice President, Biology and Translational Research, Aileron Therapeutics, Inc.
Guodong Chen, Ph.D., Principal Scientist, Bioanalytical and Discovery Analytical Sciences, Bristol-Myers Squibb
Hao Chen, Ph.D., Principal Scientist, Merck
Hao Chen, Ph.D., Sr. Scientist, Protein Technologies, Amgen, Inc.
Naresh Chennamsetty, Ph.D., Research Investigator, Bristol-Myers Squibb
Brian Chiswell, Ph.D., Owner and Founder, Dimensions BioSciences
Partha Chowdhury, Ph.D., Principal Scientist, MedImmune
Chris Chumsae, Senior Scientist, Protein Analytics, AbbVie Bioresearch Center
Kathleen A. Clouse, Ph.D., Director, Monoclonal Antibodies, FDA/CDER/OPS/OBP/DMA (Tentative)
Jennifer Cochran, Ph.D., Hitachi America Associate Professor, Bioengineering and Chemical Engineering, Stanford University
Cyrille Cohen, Ph.D., Senior Lecturer, Laboratory of Tumor Immunology, Bar-Ilan University Visiting Scientist, Surgery Branch, NCI, NIH
Matthew A. Coleman, Ph.D., Adjunct Professor, Radiation Oncology, University of California, Davis School of Medicine
Matthew H. Coleman, Ph.D., Senior Biomedical Staff Scientist, Lawrence Livermore National Laboratory
Laurence J.N. Cooper, M.D., Ph.D., Grant Taylor, W.W. Sutow
Christopher R. Corbeil, Ph.D., Research Scientist, Chemical Computing Group
Jose-Luis Corchero, Ph.D., Senior Scientist, Nanobiotechnology Group, Univ Autonoma de Barcelona; Bioengineering, Biomaterials and Nanomedicine, Centro de Investigación Biomédica en Red (CIBER-BBN)
Kyra J. Cowan, Ph.D., Scientist, BioAnalytical Sciences, Genentech, Inc.
Rick Davies, Ph.D., Reagents and Assay Development, AstraZeneca, Inc.
Heather DeGruttola, Scientist, Mass Spectrometry and Biophysical Characterization, Pfizer
Florian Deisenhammer, Ph.D., Clinical Department of Neurology, Innsbruck Medical University
Stephen Demarest, Ph.D., Research Advisor, Lilly Biotechnology Center
Binodh Desilva, Ph.D., Executive Director, Bioanalytical Sciences & Biologics, Bristol-Myers Squibb
John Desjarlais, Ph.D., Vice President, Research, Xencor
Kumar Dhanasekharan, Ph.D., Director, Process Development, Cook Pharmica LLC
Leslie Dickmann, Ph.D., Scientist, Preclinical and Translational Pharmacokinetics, Genentech
Dimiter S. Dimitrov, Ph.D., Senior Investigator, Membrane Structure & Function, National Cancer Institute, NIH
Rakesh Dixit, Ph.D., DABT, Vice President, R&D, MedImmune (AstraZeneca Biologics)
Benjamin Doranz, Ph.D., CSO, Integral Molecular, Inc.
Stefan Duebel, Ph.D., Director, Institute for Biochemistry, Biotechnology & Bioinformatics, Technical University Braunschweig
Jacques Dumas, Ph.D., Head, Protein Production, Vitry Biologics SCP, Vitry Research Center, Sanofi
Russell Dushin, Ph.D., Associate Research Fellow, Worldwide Medicinal Chemistry, Pfizer, Inc.
Paul Ko Ferrigno, Ph.D., CSO, Avacta Life Sciences
Robert L. Ferris, M.D., Ph.D., UPMC Chair, Advanced Oncologic Head and Neck Surgery; Associate Director, Translational Research; Co-Leader, Cancer Immunology Program, University of Pittsburgh Cancer Institute
Soldano Ferrone, M.D., Ph.D., Lecturer, Surgical Oncology, Surgery, Massachusetts General Hospital
Elena Feshchenko, Ph.D., Associate Director, GeneXpress, Protein Sciences Corporation
Isabel Figueroa, Associate Principal Scientist, PK/PD, Merck
Vasco Filipe, Ph.D., Research Scientist, ADOCIA
William“Jonny” Finlay, Ph.D., Director, Pfizer, Ireland
Ken Flanagan, Ph.D., Senior Scientist, Cell Biology, Prothena Biosciences
Heather Flores, Scientist, Late Stage Pharmaceutical Development, Genentech, Inc.
Barbara S. Fox, Ph.D., CEO, Avaxia Biologics, Inc.
Stanley R. Frankel, M.D., Executive Director, Medical Sciences, Amgen Rockville, Inc.
Gordon Freeman, Ph.D., Associate Professor, Medicine, Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School
Jim Freeth, Ph.D., Managing Director, Retrogenix Ltd
Fredrik Frejd, Ph.D., CSO, Vice President R&D, Biopharma, Affibody AB
Eric Furfine, Ph.D., CSO, Eleven Biotherapeutics
Melissa Geddie, Ph.D., Senior Scientist, Merrimack Pharmaceuticals
Krist Gernaey, Ph.D., Professor, Center for Process Engineering and Technology (PROCESS), Chemical and Biochemical Engineering, Technical University of Denmark
Tariq Ghayur, Ph.D., Senior Principal Scientist & Research Fellow, AbbVie Bioresearch Center
Jacob Glanville, Ph.D., CSO, Distributed Bio
Marco Gobbi, Head, Laboratory Pharmacodynamics & Pharmacokinetics, IRCCS, “Mario Negri” Institute for Pharmacological Research
Dragan Grabulovski, Ph.D., CSO, Covagen AG
Ulf Grawunder, Ph.D., CEO, NBE-Therapeutics Ltd.
Jeffrey Gray, Ph.D., Associate Professor & F. Stuart Hodgson Faculty Scholar, Chemical & Biomolecular Engineering, Johns Hopkins University
Reinhard Grisshammer, Ph.D., Biotechnology Core Laboratory, National Institute of Diabetes and Digestive and Kidney Diseases
Karl E. Griswold, Ph.D., Thayer School of Engineering; Molecular and Cellular Biology Program, Dartmouth University
Shalini Gupta, Ph.D., Director, Clinical Immunology, Amgen, Inc.
Markus Haindl, Ph.D., Group Leader, Research & Development, Roche Diagnostics GmbH, Germany
Otmar Hainzl, Ph.D., Lab Head, Biophysical Characterization, Sandoz Biopharmaceuticals, Germany
Trevor Hallam, Ph.D., CSO, Sutro BiopharmaSpeaker
Robert G. Hamilton, Ph.D., D.ABMLI, F.AAAAI, Professor of Medicine and Pathology, Johns Hopkins University School of Medicine
Carl Hansen, Ph.D., Associate Professor, Center for High-Throughput Biology, University of British Columbia, Canada
Kenta Haraya, Researcher, Chugai Pharmaceutical Co., Ltd.
Pernille Harris, Ph.D., Associate Professor, Department of Chemistry, Technical University of Denmark
Haruki Hasegawa, Ph.D., Principal Scientist, Therapeutic Discovery, Amgen, Inc.
Peter B. Heifetz, Ph.D., President and CTO, OrPro Therapeutics, Inc.
Ronald Herbst, Ph.D., Senior Director, Autoimmune Diseases, MedImmune
Chris Herring, Ph.D., Head, Protein Sciences, GlaxoSmithKline
John Heyman, Ph.D., Research Associate, School of Engineering and Applied Sciences, Harvard University
Tim Hickling, Ph.D., Associate Research Fellow, Pharmacokinetics, Dynamics and Metabolism, Pfizer, Inc
Akinori Hishiya, Ph.D., Director, Biology, Boston Strategics Corporation
David D. Ho, M.D., Scientific Director & CEO, Aaron Diamond AIDS Research Center; Irene Diamond Professor, The Rockefeller University
Mitchell Ho, Ph.D., Chief, Antibody Therapy Section, Laboratory of Molecular Biology, National Cancer Institute, NIH
Timothy Hoey, Ph.D., Senior Vice President, Cancer Biology, OncoMed Pharmaceuticals, Inc.
Alex Y. Huang, M.D., Ph.D., Associate Professor, Pediatrics, Pathology & Biomedical Engineering; Director, Pediatric Hematology-Oncology Fellowship Program, Rainbow Babies & Children's Hospital, Case Western Reserve University School of Medicine
ChiChi Huang, Ph.D., Scientific Director, Antibody Drug Discovery, Janssen R&D, LLC
Nathan C. Ihle, Ph.D., Executive Director, CMC Strategy & Management, Seattle Genetics, Inc.
David Jackson, Ph.D., Principle Scientist, ADC Discovery, Igenica, Inc.
Elizabeth M. Jaffee, M.D., The Dana & Albert “Cubby” Broccoli Professor, Oncology; Co-Director, Gastrointestinal Cancers Program; Associate Director, Translational Research, Johns Hopkins University
Bahija Jallal, Ph.D., Executive Vice President, MedImmune
Donald Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming
Vibha Jawa, Ph.D., Principal Scientist, Clinical Immunology, Amgen, Inc.
Kristian Jensen, Ph.D., Vice President, Research, Dutalys GmbH
Michael C. Jensen, M.D., Professor, Pediatrics, University of Washington School of Medicine; Director, Ben Towne Center for Childhood Cancer Research/Seattle Children's Research Institute; Joint Member, Program in Immunology, Fred Hutchinson Cancer Research Center
Yun Jiang, Ph.D., Senior Scientist Project Team Leader Upstream, Drug Design & Development, Swedish Orphan Biovitrum AB
Jan Johansson, Ph.D., CEO and President, Artery Therapeutics, Inc.
Shefali Kakar, Ph.D., Director, Oncology Clinical Pharmacology, Novartis
Adeela Kamal, Ph.D., Associate Director, Oncology Research, MedImmune
Guna Kannan, Ph.D., Principal Scientist and Group Leader, Biologics Optimization, Amgen, Inc.
Brian K. Kay, Ph.D., Professor and Head, Biological Sciences; LAS Distinguished Professor, University of Illinois, Chicago
Hubert Kettenberger, Ph.D., Principal Scientist, Large Molecule Research, Roche Diagnostics GmbH, Germany
Nikolai Khramtsov, Ph.D., Associate Director, Upstream Development, Product Realization, Protein Sciences Corp.
Peter Kiener, Ph.D., CSO, Ambrx, Inc.
Jeong Kim, Ph.D., Scientist, Cancer Immunotherapy, Genentech, Inc.
David King, Ph.D., CSO, AnaptysBio, Inc.
Marina Kirkitadze, Ph.D., Deputy Director, Analytical Research & Development, Sanofi Pasteur, Canada
Scott Klakamp, Ph.D., Principal Consultant, Biophysical Chemistry, SKD Consulting LLC
Christian Klein, Ph.D., Discovery Oncology oDTA, Pharma Research and Early Development (pRED), Roche Glycart AG
Hendrik Knoetgen, Ph.D., Head, LMR Penzberg & pRED, Roche Diagnostics GmbH
Curtis Knox, Vice President, Marketing & Sales, Lucigen Corp.
James T. Koerber, Ph.D., Life Science Research Fellow, Pharmaceutical Chemistry, University of California, San Francisco
Manfred Konrad, Ph.D., Enzyme Biochemistry Laboratory, Max Planck Institute for Biophysical Chemistry
Roland E. Kontermann, Ph.D., Mildred Scheel Professor, Biomedical Engineering, University of Stuttgart
Joseph Kovalchin, Ph.D., Associate Director, Pharmacology, Eleven Biotherapeutics, Inc.
David Kranz, Ph.D., Phillip A. Sharp Professor, Biochemistry, University of Illinois
Sriram Krishnamoorthy, Ph.D., Scientist, Preclinical and Clinical Development (Hemophilia), Biogen Idec, Inc.
Stefan Kubick, Ph.D., Group Manager, Fraunhofer Institute for Biomedical Engineering IBMT
Bob Kuczenski, Ph.D., Engineer II, Genentech
Alex Kudrin, M.D., MBA, MRCP, MFPM, Vice President & Head,Global Development, Celltrion, Inc.
Joseph Kutza, Ph.D., Director, CMC Regulatory Affairs, MedImmune
Aran F. Labrijn, Ph.D., Senior Scientist, Antibody Sciences, Genmab BV
Jean Lachowicz, Ph.D., CSO, R&D, Angiochem
Michelle LaFond, Director, Bioreactor Scale-Up and Development, Regeneron Pharmaceuticals
Kasper Lamberth, Ph.D., Head, Immunogenicity Prediction & Tolerance, Novo Nordisk A/S
Joseph C. Laning, Ph.D., Co-founder, Ingenium BioTherapy Corporation; Vice President, Research & Development, Provia Labs
Jesper Lau, Ph.D., Vice President, Diabetes Protein & Peptide Chemistry, Novo Nordisk A/S
Alex Lazar, Ph.D., Head, Analytical and Pharmaceutical Sciences, Immunogen, Inc.
Timothy Lee, Ph.D., Senior Scientific Consultant, Biomanufacturing, Latham Biopharm Group
Oren Levy, Ph.D., Instructor in Medicine, Harvard Medical School
Luke Li, Ph.D., Head, Global Biotherapeutics Technologies & Pharmaceutical Sciences, External R&D Innovation
Chris Lloyd, Ph.D., Scientist, Antibody Discovery & Protein Engineering, MedImmune Ltd.
Peter Lloyd, Head, PK/PD, Biologics, Novartis
David C. Lowe, Ph.D., Fellow, R&D, MedImmune, Ltd.
Timothy B. Lowinger, Ph.D., CSO, Mersana Therapeutics, Inc.
Alexey Lugovskoy, Ph.D., Vice President, Therapeutics, Merrimack Pharmaceuticals
Donna Luisi, Ph.D., Senior Principal Scientist, Biopharmaceutical R&D, Pfizer
Robert Lyon, Ph.D., Associate Director, Protein Chemistry, Seattle Genetics
Donghui Ma, Ph.D., CSO, Immunology, OriGene
Robert Mabry, Ph.D., Associate Director, Antibody Discovery and Bispecific Engineering, Adimab LLC
Matthew Macauley, Ph.D., Researcher, Paulson Laboratory, Chemical Physiology, The Scripps Research Institute
Shannon MacMilian, MSc, Principal Scientist, Biotherapeutic Pharmaceutical Sciences R&D, Pfizer, Inc.
Chikkathur N. Madhavarao, Ph.D., Senior Staff Fellow, Therapeutic Proteins, OBP, OPS, CDER, FDA
Donald E. Mager, Ph.D., Associate Professor, Pharmaceutical Sciences, University at Buffalo
John Maher, Consultant and Senior Lecturer in Immunology, Department of Research Oncology, King's College London
James D. Marks, M.D., Ph.D., Professor, Anesthesia & Pharmaceutical Chemistry, University of California, San Francisco; Chief, Anesthesia and Vice Chairman, Anesthesia & Perioperative Care, San Francisco General Hospital
Ewa Marszal, Ph.D., Chemist, Hematology, Office of Blood Research and Review, Center for Biologics Evaluation and Research, FDA
Krzysztof Masternak, Ph.D., Head, Biology, Novimmune SA
Marcela V. Maus, M.D., Ph.D., Director, Translational Medicine and Early Clinical Development, Translational Research Program, Abramson Cancer Center, University of Pennsylvania
Jennifer Maynard, Ph.D., Assistant Professor, Chemical Engineering, University of Texas, Austin
Lorenz Mayr, Ph.D., Vice President & Global Head, Reagents & Assay Development, AstraZeneca
John McCafferty, Ph.D., Professor, Biochemistry, Cambridge University
Monika Meier, Ph.D., Postdoctoral Researcher, Development Analytics, Roche Diagnostics GmbH, Germany
Jens Meiler, Ph.D., Associate Professor, Chemistry, Associate Professor, Pharmacology, Vanderbilt University Medical Center
Rima Menassa, Ph.D., Southern Crop Protection and Food Research Centre, Agriculture and Agri-Food Canada
Deborah Meshulam, Director, Contract Manufacturing, ImmunoGen, Inc.
Anne Messer, Ph.D., Professor, Biomedical Sciences, University at Albany; Senior Scientist, Neural Stem Cell Institute
Debra M. Meyer, BSc, Senior Principal Scientist, Analytical R&D, Biotherapeutics Pharmaceutical Sciences, Pfizer, Inc.
Jeffrey S. Miller, M.D., Deputy Director, Masonic Cancer Center; Deputy Director, Clinical and Translational Sciences Institute; Director, Cancer Experimental Therapeutics Initiative, University of Minnesota
Jamie Moore, Ph.D., Senior Scientist & Director, Early Stage Pharma Development, Genentech, Inc.
Paul Moore, Ph.D., Vice President, Cell Biology & Immunology, Macrogenics
Hong Moulton, Ph.D., Associate Professor, Senior Researcher, Biomedical Sciences, Oregon State University
Mark R. Nagel, Senior Research Associate, GE Service Manager, Protein Chemistry, Genentech, Inc.
Chakravarthy Narasimhan, Ph.D., Senior Principal Scientist, Bioprocess Development, Merck & Co.
Horacio G. Nastri, Ph.D., Director, Biotherapeutics, Center for Therapeutic Innovation (CTI), Pfizer, Inc.
Kelly Neelon, Ph.D., Associate Director, Drug Product Formulation and Development, Momenta Pharmaceuticals
Jennifer Nemeth, Ph.D., Program Leader, Biologics Research, Janssen R&D
Dario Neri, Ph.D., Institute of Pharmaceutical Sciences, Chemistry and Applied Biosciences, Swiss Federal Institute of Technology Zurich
J. Michael Nicholas, Ph.D., Vice President, Specialty Life Cycle Initiatives, Teva Pharmaceuticals
Ahuva Nissim, Ph.D., Senior Lecturer, Molecular Targeting, Biochemical Pharmacology, William Harvey Research Institute, Queen Mary University of London
David O’Connell, Ph.D., Director, Masters Programs in Biotechnology, School of Biomolecular & Biomedical Research, University College Dublin; Conway Institute of Biomolecular & Biomedical Research, UCD Belfield
Erika Orbán, Ph.D., Postdoctoral Fellow, Institute of Biophysical Chemistry, Goethe University
Steven Orcutt, Research Scientist, Janssen
Ayse Meric Ovacik, Senior Scientist, Biologics DMPK & Disposition, Merck
Tadas Panavas, Ph.D., Principal Scientist, Molecular Protein and Biosciences, Janssen
Nancy L. Parenteau, Ph.D., Co-Founder, President & CSO, Ingenium BioTherapy Corporation
Peter U. Park, Ph.D., Vice President, Biology, Mersana Therapeutics
Ira Pastan, M.D., NIH Distinguished Investigator, Co-Chief, Laboratory of Molecular Biology, National Cancer Institute, National Institutes of Health
Belinda Pastrana, Ph.D., Professor, Chemistry, University of Puerto Rico
Josh Pearson, Ph.D., Senior Scientist, Biochemistry & Biophysics Group, Pharmacokinetics & Drug Metabolism, Amgen, Inc.
Jean-Philippe Pellois, Ph.D., Associate Professor, Biochemistry and Biophysics, Texas A&M University
Bradley L. Pentelute, Ph.D., Assistant Professor, Massachusetts Institute of Technology
Robert Pierce, M.D., Executive Director, Pathology, MRL-Palo Alto, Merck
Thomas Pillow, Ph.D., Scientist, Discovery Chemistry, Genentech
Frederic Pio, Ph.D., Associate Professor, Molecular Biology & Biochemistry, Simon Fraser University, Canada
Jaume Pons, Ph.D., CSO, Pfizer's Rinat Laboratories
Joe Ponte, Ph.D., Senior Scientist, Immunogen, Inc.
David Poon, Ph.D., Director, External R&D and Alliances, Zymeworks Inc.
Matthew Porteus, M.D., Ph.D., Associate Professor, Pediatrics (Cancer Biology), Stanford School of Medicine
Yongchang Qiu, Ph.D., Group Director and Head, Bioanalytical and Biomarker Development, Shire, Inc.
Terence H. Rabbitts, FRS FMedSci, Professor, Molecular Biology, Weatherall Institute of Molecular Medicine, MRC Molecular Hematology Unit, University of Oxford
David Rabuka, Ph.D., CSO, Redwood Bioscience
Laszlo Radvanyi, Ph.D., Professor, Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center
Sylvain Raimondi, Ph.D., Head, Analytical Unit, Novimmune
G. Jonah Rainey, Ph.D., Senior Scientist, ADPE, MedImmune, LLC
Nitya G. Ray, Ph.D., Senior Vice President, Manufacturing, Process Sciences/Manufacturing, Progenics Pharmaceuticals, Inc.
Sai Reddy, Ph.D., Assistant Professor, Biosystems Science and Engineering, ETH Zurich, Switzerland
Alan T. Remaley, M.D., Ph.D., Section Chief, Lipoprotein Metabolism Laboratory, National Institutes of Health (NIH)
Jörg Thomas Regula, Ph.D., Pharma Research and Early Development (pRED), Large Molecule Research (LMR), Roche Diagnostics GmbH
Christopher L. Reyes, Ph.D., Vice President, Research & Development Biologics, Bionomics, Inc.
Sebastien Ribault, Ph.D., Director, Development and BioProduction, Merck Biodevelopment
Sue Richards, Ph.D., Global Deputy and Head, Clinical Laboratory Sciences, DSAR, SANOFI/Genzyme
Anne Skaja Robinson, Ph.D., Catherine and Henry Boh Professor, Engineering; Chair, Chemical and Biomolecular Engineering, Neuroscience Program Faculty Member; Professor and Chair, Chemical and Biomolecular Engineering, Tulane University
Dan Rock, Ph.D., Scientific Director, Pharmacokinetics and Drug Metabolism, Amgen, Inc.
Robert Roth, Ph.D., Associate Principal Scientist, Innovative Medicines, Discovery Sciences, AstraZeneca
Bonnie Rup, Ph.D., Research Fellow, Immunogenicity Sciences Lead, Pfizer, Inc.
Michel Sadelain, M.D., Ph.D., Director, Center for Cell Engineering & Gene Transfer and Gene Expression Laboratory; Stephen and Barbara Friedman Chair, Memorial Sloan-Kettering Cancer Center
Markku Saloheimo, Ph.D., VTT Technical Research Centre of Finland
Zenjiro Sampei, Research Scientist, Research Division, Chugai Pharmaceutical Co., Ltd.
Kristi Sarno, Chair, Greater Boston Chapter, Women in Bio; Director, Business Development, Pfenex, Inc.
Philippe Sarret, Ph.D., Professor, Physiology and Biophysics, University of Sherbrooke
Aaron K. Sato, Ph.D., Vice President Research, Sutro Biopharma
Jonas Schaefer, Ph.D., Head, High-Throughput Laboratory, Biochemistry, University of Zurich, Switzerland
David A. Scheinberg, M.D., Ph.D., Chair, Molecular Pharmacology and Chemistry Program, Memorial Sloan-Kettering Cancer Center
Stefan Schmidt, Ph.D., Vice President, DSP, Rentschler Biotechnology
Joyce A. Schroeder, Ph.D., Professor, Molecular and Cellular Biology, Program in Cancer Biology, BIO 5 Institute, Arizona Cancer Center, University of Arizona
Yulius Setiady, Ph.D., Principal Scientist, Discovery Research, ImmunoGen, Inc.
Dhaval K. Shah, Ph.D., Assistant Professor, Pharmaceutical Sciences, School of Pharmacy and Pharmaceutical Sciences, University at Buffalo
Whitney Shatz, Research Associate, Genentech
Ben-Quan Shen, M.D., Senior Scientist, PKPD, Genentech, Inc.
Girja Shukla, Ph.D., Associate Professor, Surgery; Member, Vermont Cancer Center, University of Vermont College of Medicine
Pratap Singh, Ph.D., Senior Principal Scientist, Pfizer, Inc.
Satish Singh, Ph.D., Research Fellow and Group Leader, Pfizer; Member, 787 Expert Panel, U.S. Pharmacopeial Convention (USP)
Louise Slater, Ph.D., Postdoctoral Fellow, Antibody Discovery and Protein Engineering, MedImmune
Eric Smith, Ph.D., Associate Director, Bispecifics, Regeneron Pharmaceuticals
Ernest S. Smith, Ph.D., CSO & Senior Vice President, Research, Vaccinex, Inc.
Holly Smith, Principal Research Scientist, Toxicology, Eli Lilly & Co.
Dan Some, Ph.D., Principal Scientist, Wyatt Technology Corporation
Yongcheng Song, Ph.D., Assistant Professor, Pharmacology, Baylor College of Medicine
Christoph Spiess, Ph.D., Scientist, Antibody Engineering and Structural Biology, Genentech, Inc.
Sebastian Spindeldreher, Ph.D., Director, Biologics Safety and Disposition, Novartis Pharma AG
Marlitt Stech, MSc, Cell-Free Protein Synthesis, Fraunhofer IBMT-Potsdam
Kendra Steele, Ph.D., Research Scientist, ParaTechs Corp.
William Stohl, M.D., Ph.D., Professor, Medicine, Rheumatology, Keck School of Medicine, University of Southern California
Patrik Strömberg, Ph.D., Principal Scientist, Drug Design and Development, Swedish Orphan Biovitrum (Sobi), Sweden
Meena Subramanyam, Ph.D., Vice President, Translational Medicine, Biogen Idec, Inc.
Siguang Sui, Ph.D., Development Scientist I, Upstream Development, Alexion Pharmaceuticals, Inc.
Siddharth Sukumaran, Ph.D., Associate Scientist, Pharmacokinetics and Pharmacodynamics, Genentech, Inc.
Margaret Sullivan, Distinguished Professor in Pediatrics; MDACC Section Chief, Cell Therapy, Children’s Cancer Hospital, Division of Pediatrics (Unit 907); Associate Director, CCIR; Director, Immunology Laboratory of Physician Scientists, Department of Immunology, MD Anderson Cancer Center
Steven J. Swanson, Ph.D., Executive Director, Medical Sciences (Clinical Immunology), Amgen, Inc.
Michael Szardenings, Ph.D., Ligand Development Unit, Coordinator JLCI (CNUHH, Hwasun, Korea), Fraunhofer Institute for Cell Therapy and Immunology
Mohammad Tabrizi, Ph.D., Head & Senior Fellow, PK/PD, Merck
Shu-Wen Teng, Scientist, Millennium Pharmaceuticals, The Takeda Oncology Company
Greg Thurber, Ph.D., Assistant Professor, Chemical Engineering & Biomedical Engineering, University of Michigan
Marco Timmers, Ph.D., CSO, New Molecular Entities, Synthon Biopharmaceuticals
Elizabeth Topp, Ph.D., Dane O. Kildsig Chair and Head, Industrial and Physical Pharmacy, Purdue University
Michael G. Tovey, Ph.D., INSERM Director, Research, Laboratory of Biotechnology and Applied Pharmacology, ENS-Cachan
Malgorzata Tracka, MS, Scientist II, Formulation Sciences, MedImmune
Pamela A. Trail, Ph.D., Vice President, Oncology, Regeneron Pharmaceuticals
Becky Tu-Sekine, Ph.D., Research Associate, Biological Chemistry, Johns Hopkins University School of Medicine
Kendrick Turner, Ph.D., Postdoctoral Fellow, Center for Bio/Molecular Science and Engineering, U.S. Naval Research Laboratory
Jesper Valbjørn, Vice President, CMC Operations, Genmab A/S
Aad van de Leur, MSc, COO, Biopharmaceutical Development, Synthon Biopharmaceuticals B.V.
Guus van Dongen, Ph.D., Professor, Radiology and Nuclear Medicine, Preclinical Imaging, VU University Medical Center Amsterdam
Marylene Vandevenne, Ph.D., Postdoctoral Research Associate, Mackay Laboratory, The School of Molecular Bioscience, The University of Sidney - Australia
Samadhi Vitharana, Ph.D., Senior Scientist, Core Sciences & Technologies, Takeda California
Eric Wakshull, Ph.D., Senior Scientist and Group Leader, Bioanalytical Sciences, Genentech, Inc.
Herman Waldman, Ph.D., Emeritus Professor of Pathology, Therapeutic Immunology Group, Sir William Dunn School of Pathology, University of Oxford, United Kingdom
Mikkel Wandahl Pedersen, Ph.D., Director, Cancer Biology, Symphogen A/S
Zhirui Wang, DVM, Ph.D., Assistant Professor, Harvard Medical School; Technical Director, MGH-DF/HCC Recombinant Protein Expression and Purification Core, Transplantation Biology Research Center, Massachusetts General Hospital
Louis M. Weiner, M.D., Director, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center
David Weis, Ph.D., Assistant Professor, Department of Chemistry, University of Kansas
Mark Welch, Ph.D., Director, Gene Design, DNA2.0 Inc.
Maria Wendt, Ph.D., Senior Scientific Consultant, Biologics, Genedata
Nancy Whiting, Pharm.D., Senior Medical Director, Seattle Genetics
Sujeewa D Wijesuriya, Ph.D., Senior Scientist, XOMA (US) LLC
K. Dane Wittrup, Ph.D., J.R. Mares Professor, Chemical Engineering & Bioengineering, Massachusetts Institute of Technology
David Wraith, Ph.D., Professor of Experimental Pathology, School of Cellular and Molecular Medicine, University of Bristol, United Kingdom
Lawren Wu, Ph.D., Senior Scientist, Immunology, Genentech, Inc.
Wen Jin Wu, M.D., Ph.D., Senior Investigator, Monoclonal Antibodies, Office of Biotechnology Products, Office of Pharmaceutical Science, Center for Drug Evaluation and Research, FDA
April Xu, Ph.D., Sr. Principal Scientist, BioBtx-ARD, Prizer
Yingda Xu, Ph.D., Group Leader, Protein Analytics, Adimab
George D. Yancopoulos, M.D., Ph.D., President, Regeneron Laboratories; CSO, Regeneron Pharmaceuticals, Inc.
Alexei Yeliseev, Ph.D., Staff Scientist and Head, Protein Expression Group, LMBB, NIH
Nicholas Yoder, Ph.D., Scientist, Biochemistry, ImmunoGen, Inc.
Xiang-Qing Yu, Ph.D., Principal Clinical Pharmacokineticist, MedImmune
Alex Yurkovetskiy, Ph.D., Senior Director, Chemistry, Mersana Therapeutics
Marie M. Zhu, Ph.D., Director, Process Sciences, Technical Operations, Agensys Inc., an affiliate of Astellas, Inc.